Rheumatology 2001; 40: 896-906
© 2001 British Society for Rheumatology
Report |
Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups
The University of Queensland, Edith Cavell Building, Royal Brisbane Hospital, Herston, Queensland 4029, Australia and
1 Division of Rheumatology and Immunology, University of Maryland, Baltimore, MD 21201, USA
 |
Introduction |
|---|
The International League of Associations for Rheumatology (ILAR) has been meeting with the World Health Organization (WHO) on a regular basis to discuss issues of mutual interest. Over the last few years these meetings have focused on the development of outcome measures in the rheumatic diseases, principally driven through OMERACT (Outcome Measures for Arthritis Clinical Trials). OMERACT has now held five meetings addressing a number of important areas in rheumatology, including clinical and imaging outcome measures, health economics and drug safety. The advantage of the WHO/ILAR Task Force Meeting has been to ratify these measures and allow them to be promulgated widely around the world.
This paper summarizes discussions which took place at the Sixth Joint WHO/ILAR Task Force Meeting on Rheumatic Diseases which was held in Geneva on 16 January 2000. This meeting reviewed a number of outcome measures for rheumatic diseases that had been developed over the past
|
Outcome measures for rheumatoid arthritis |
|---|
|
Outcome measures for osteoarthritis |
|---|
|
Outcome measures for ankylosing spondylitis |
|---|
|
Outcomes measures for systemic lupus erythematosus |
|---|
|
Outcome measures for osteoporosis |
|---|
Randomized trials where prevention of rapid bone loss was the primary aim
Randomized trials of fracture prevention in high-risk populations
|
Criteria for the classification of rheumatic diseases |
|---|
Ankylosing spondylitis
The 1961 Rome criteria for ankylosing spondylitis [8]
The 1966 New York criteria for ankylosing spondylitis [9]
The European Spondyloarthropathy Study Group classification for spondyloarthropathy [10]
Domains of the core sets for SM-ARD/physical therapy, clinical record keeping and DC-ART as endorsed by Assessment in Ankylosing Spondylitis Working Group/OMERACT/ILAR [11]
|
Behçet's disease [12] |
|---|
|
Churg–Strauss syndrome [13] |
|---|
|
Fibromyalgia [14] |
|---|
Pain in 11 of 18 tender point sites on digital palpation
|
Giant cell arteritis [15] |
|---|
The 1990 criteria for the classification of giant cell (temporal) arteritis (traditional format)
Criteria and definitions used for the classification of giant cell (temporal) arteritis (tree format)
|
Gout [16] |
|---|
|
Henoch–Schönlein purpura [17] |
|---|
The 1990 criteria for the classification of Henoch–Schönlein purpura (traditional format)
Criteria and definitions used for the classification of Henoch–Schönlein purpura (tree format)
|
Hypersensitivity vasculitis [18] |
|---|
The 1990 criteria for the classification of hypersensitivity vasculitis (traditional format)
Criteria and definitions used for the classification of hypersensitivity vasculitis (tree format)
|
Kawasaki syndrome [19] |
|---|
Principal symptoms
Other significant symptoms or findings
|
Osteoarthritis of the hand [20] |
|---|
Classification criteria for osteoarthritis of the hand (traditional format)
|
Osteoarthritis of the hip [21] |
|---|
Combined clinical (history, physical examination, laboratory) and radiographic classification criteria for osteoarthritis of the hip (traditional format)
Combined clinical (history, physical examination, laboratory) and radiographic classification criteria for osteoarthritis of the hip (classification tree format)
|
Osteoarthritis of the knee [22] |
|---|
Criteria for the classification of idiopathic osteoarthritis of the knee
|
Polyarteritis nodosa [23] |
|---|
The 1990 criteria for the classification of polyarteritis nodosa (traditional format)
|
Polymyalgia rheumatica [24] |
|---|
Characteristics
|
Polymyositis and dermatomyositis [25] |
|---|
Criteria
|
Reiter's syndrome [26] |
|---|
Percentage sensitivity and specificity of various criteria for typical Reiter's syndrome (initial episode)
|
Rheumatic fever [27] |
|---|
Guidelines for the diagnosis of an initial attack of rheumatic fever (Jones criteria, 1992 update)
Minor manifestations
|
Rheumatoid arthritis [28] |
|---|
The 1987 revised criteria for the classification of rheumatoid arthritis (traditional format)
|
Sjögren's syndrome [29] |
|---|
Preliminary criteria for the classification of Sjögren's syndrome
|
Spondyloarthropathies [30] |
|---|
|
Systemic lupus erythematosus [31, 32] |
|---|
The 1982 revised criteria for the classification of systemic lupus erythematosus
|
Systemic sclerosis [33] |
|---|
American Rheumatism Association Scleroderma Criteria Cooperative Study (SCCS): preliminary clinical criteria for systemic sclerosis (excludes localized scleroderma and pseudosclerodermatous disorders)
|
Takayasu's arteritis [34] |
|---|
The 1990 criteria for the classification of Takayasu's arteritis (traditional format)
|
Wegener's granulomatosis [35] |
|---|
The 1990 criteria for the classification of Wegener's granulomatosis (traditional format)
Criteria and definitions used for the classification of Wegener's granulomatosis (tree format)
|
Preliminary criteria for the classification of juvenile ideopathic arthritis |
|---|
Classification of juvenile idiopathic arthritis
|
Notes |
|---|
|
References |
|---|
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. Castelnuovo, P. Cross, S. Mt-Isa, A. Spencer, M. Underwood, and on behalf of the TOIB study team Cost-effectiveness of advising the use of topical or oral ibuprofen for knee pain; the TOIB study [ISRCTN: 79353052] Rheumatology, July 1, 2008; 47(7): 1077 - 1081. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G Peat, E Thomas, R Duncan, L Wood, E Hay, and P Croft Clinical classification criteria for knee osteoarthritis: performance in the general population and primary care Ann Rheum Dis, October 1, 2006; 65(10): 1363 - 1367. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. L. Soeken, S. A. Miller, and E. Ernst Herbal medicines for the treatment of rheumatoid arthritis: a systematic review Rheumatology, May 1, 2003; 42(5): 652 - 659. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P Riemsma, E. Taal, J. R Kirwan, and J. J Rasker Patient education programmes for adults with rheumatoid arthritis BMJ, September 14, 2002; 325(7364): 558 - 559. [Full Text] [PDF]
|
|